Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,053 | 42,310 | 125,108 | 134,565 | 81,899 |
| Marketable Securities | 84,654 | 70,972 | N/A | N/A | N/A |
| Receivables | N/A | N/A | N/A | N/A | 998 |
| TOTAL | $113,846 | $115,185 | $126,941 | $138,890 | $86,148 |
| Non-Current Assets | |||||
| PPE Net | 542 | 686 | 949 | 1,209 | 1,674 |
| Intangibles | 10,502 | 10,502 | 10,502 | 10,502 | 10,502 |
| Other Non-Current Assets | 210 | 210 | 131 | 131 | 131 |
| TOTAL | $11,254 | $11,398 | $11,582 | $11,842 | $12,307 |
| Total Assets | $125,100 | $126,583 | $138,523 | $150,732 | $98,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 474 | 2,366 | 681 | 283 | 1,811 |
| Accrued Expenses | 7,498 | 6,523 | 4,574 | 6,317 | 7,033 |
| Other current liabilities | 0 | 370 | 360 | 360 | 51,830 |
| TOTAL | $7,972 | $9,259 | $5,615 | $6,960 | $60,674 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,277 | 12,457 | 10,015 | 10,470 | 14,893 |
| TOTAL | $25,581 | $12,750 | $10,293 | $10,740 | $15,047 |
| Total Liabilities | $33,553 | $22,009 | $15,908 | $17,700 | $75,721 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,134 | 13,152 | 10,828 | 10,672 | 10,394 |
| Common Shares | 18 | 11 | 11 | 10 | 10 |
| Retained earnings | -434,802 | -404,177 | -383,412 | -370,263 | -334,924 |
| Other shareholders' equity | 41 | -34 | 0 | 0 | 0 |
| TOTAL | $91,547 | $104,574 | $122,615 | $133,032 | $22,734 |
| Total Liabilities And Equity | $125,100 | $126,583 | $138,523 | $150,732 | $98,455 |